During the past decade, Universitatsklinikum Hamburg-Eppendorf / IVDP conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Universitatsklinikum Hamburg-Eppendorf / IVDP" are "Breast Neoplasms" (1 trials), "Plaque Psoriasis" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Universitatsklinikum Hamburg-Eppendorf / IVDP" in a lesser frequency.

Most popular intervention types in "Universitatsklinikum Hamburg-Eppendorf / IVDP" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Apremilast" (1 trials), "CC-486" (1 trials), "Docetaxel" (1 trials) and "Fulvestrant" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitatsklinikum Hamburg-Eppendorf / IVDP" are 1 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Universitatsklinikum Hamburg-Eppendorf / IVDP". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Universitatsklinikum Hamburg-Eppendorf / IVDP, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Universitatsklinikum Hamburg-Eppendorf / IVDP, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".